StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$27.44−0.18 (-0.67%)

Close on Nov 20, 2026Market cap $3.39BP/E –Yield –

Parabilis Medicines gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Parabilis Medicines

Parabilis Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Parabilis Medicines figures

See a number that looks wrong?